The global infection control market size was estimated at USD 52.38 billion in 2024, and is projected to reach USD 74.21 billion by 2030, growing at a CAGR of 6.1% from 2025 to 2030. A primary factor fueling this growth is the increasing frequency of surgical and clinical procedures, which inherently require stringent infection prevention protocols to minimize the risk of healthcare-associated infections (HAIs).

Technological innovations have played a transformative role in advancing infection control practices across healthcare settings. Notable developments include the deployment of automated disinfection systems, ultraviolet (UV) light-based sanitization technologies, antimicrobial surface coatings, and state-of-the-art air filtration systems. These technologies have shown the potential to reduce hospital-acquired infections by up to 30%, thereby supporting their growing adoption and contributing to the market’s expansion.

In addition to technology, there is a rising trend of outsourcing sterilization services, allowing healthcare facilities to achieve high levels of sterilization efficiency while reducing internal operational burdens. The launch of novel and highly effective sterilizing solutions further enhances infection control standards and fosters market growth.

Another crucial growth driver is the increased involvement of government bodies in promoting intensive infection control practices. These efforts are manifested through strategic initiatives, regulatory guidance, and awareness campaigns. Government organizations are consistently issuing updated guidelines aimed at improving infection prevention and control (IPC) measures on a global scale. Such proactive involvement is expected to maintain a positive influence on the market throughout the forecast timeline.

For example, the World Health Organization (WHO) has released comprehensive guidelines for the prevention and control of pandemic- and epidemic-prone acute respiratory diseases within healthcare environments. These recommendations include standard precautions such as proper hand hygiene, use of personal protective equipment (PPE), and protocols for effective disinfection and sterilization practices.

Key Market Trends & Insights:

• North America emerged as the leading region in the infection control market, capturing the largest revenue share of 48.3% in 2024. This dominance is attributed to the well-established healthcare infrastructure, high awareness regarding infection prevention, and strong presence of major industry players across the region.

• Within North America, the United States contributed the highest revenue share to the regional market in 2024. This significant share is driven by a combination of factors, including a high volume of surgical procedures, increased healthcare expenditure, stringent infection control regulations, and ongoing technological advancements in sterilization and disinfection.

• When analyzed by product type, the consumables segment led the infection control market in 2024, accounting for the largest share of overall revenue. This is primarily due to the high and recurring demand for disposable items such as sterilization wraps, face masks, gloves, disinfectants, and other single-use supplies, which are essential for maintaining hygiene standards in healthcare settings.

• From the perspective of end users, the hospital segment held the dominant revenue share in 2024. Hospitals have the highest infection control requirements due to the volume and complexity of medical procedures performed. This segment is also projected to experience the fastest compound annual growth rate (CAGR) throughout the forecast period from 2025 to 2030, fueled by the increasing number of hospital admissions, rising surgical interventions, and growing emphasis on patient safety and regulatory compliance.

Order a free sample PDF of the Infection Control Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 52.38 Billion

• 2030 Projected Market Size: USD 74.21 Billion

• CAGR (2025-2030): 6.1%

• North America: Largest market in 2024

• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights:

The competitive landscape of the infection control market is characterized by the extensive use of collaborative strategies by leading industry players such as Advanced Sterilization Products, STERIS, and 3M. These key companies hold a dominant share of the market, largely due to their active engagement in various strategic initiatives. They continue to strengthen their market positions through mergers and acquisitions, new product development, and geographic expansion, enabling them to expand their global footprint and diversify their product offerings.

Among these leaders, STERIS Life Sciences stands out for offering a comprehensive portfolio of infection control solutions. Its product lineup includes sterilization equipment, a wide array of disinfectants, and cleanroom-related supplies, all specifically tailored to meet the stringent needs of pharmaceutical and biotechnology industries. These solutions are designed to ensure the maintenance of sterile environments and support compliance with global regulatory standards, making STERIS a preferred partner in highly controlled production environments.

Similarly, Belimed is recognized for its diverse portfolio of infection control technologies, which includes washer-disinfectors, steam sterilizers, and ultrasonic washers. These solutions are engineered to support the safe, effective, and efficient reprocessing of medical instruments within hospitals and other healthcare facilities. Belimed’s offerings help ensure both patient safety and the operational efficiency of healthcare institutions by meeting the high standards required for instrument cleanliness and sterilization.

Key Players

• 3M

• Belimed AG

• O&M Halyard or its affiliates.

• GETINGE AB (publ) Corporate

• ASP

• MATACHANA

• Sterigenics U.S., LLC - A Sotera Health company

• MMM Group

• Medivators Inc.

• STERIS.

• Midmark Corporation.

• W&H

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The infection control market is growing steadily due to increasing awareness of healthcare-associated infections and advancements in infection prevention technologies. Rising demand for effective hygiene products and stringent government regulations are driving market expansion. Innovations in disinfectants, sterilization methods, and protective equipment continue to shape the industry’s future, emphasizing the importance of infection control across healthcare settings.